In the carton
- ✓ One pre-filled 3 ml multi-dose research pen: Retatrutide 32 mg (32 mg · 3 ml)
- ✓ 8 pen needles
- ✓ Printed instruction leaflet
- ✓ Verification sticker
- ✓ Batch label with a QR link to the Certificate of Analysis
- ✓ Insulated cold-chain packaging with a cooling element and temperature indicator
Retatrutide 32 mg · 3 ml
Retatrutide 32 mg supplied as a pre-filled multi-dose research pen (3 ml solution). Retatrutide is a synthetic GIP, GLP-1 and glucagon receptor tri-agonist peptide used in laboratory studies of multi-receptor incretin pharmacology. Batch HPLC-tested, Certificate of Analysis published. Supplied strictly for laboratory research use. Not for human or veterinary use.
Checkout requires an account and the research-use declaration.
Research use only. For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application. This product is not a medicine, food supplement or cosmetic, and no medical, therapeutic or performance claims are made or implied. Read our research use only policy
Specification
| Compound | Retatrutide |
|---|---|
| CAS number | 2381089-83-2 |
| Molecular formula | C221H342N46O68 |
| Declared quantity | 32 mg |
| Format | Solution in a sealed, pre-filled multi-dose research pen (32 mg · 3 ml) |
| Purity (HPLC) | 98.75% |
| Batch | RET3254 |
| Storage | 2–8 °C, protected from light, do not freeze |
| Intended use | Laboratory research use only. Not for human or veterinary use. |
One sealed, pre-filled 3 ml multi-dose research pen with a batch label and a QR link to the Certificate of Analysis, shipped in insulated cold-chain packaging with a cooling element and a temperature indicator. The carton also contains 8 pen needles, a printed instruction leaflet and a verification sticker.
An independent laboratory tests every batch by HPLC for identity and purity. The Certificate of Analysis for this product is published below and on our certificates page; the batch number on the certificate matches the batch printed on the label.
Store refrigerated at 2–8 °C. Protect from light. Do not freeze. Keep out of the reach of children and animals. Dispose of in accordance with local regulations.
Orders placed before 12:00 (CET) on a business day are dispatched the same day in cold-chain packaging, tracked with DPD, and arrive in 3–5 business days. Unopened products can be returned within 30 days of delivery; damaged products are replaced free of charge.
Retatrutide
What Retatrutide is
Retatrutide (LY3437943) is a synthetic single peptide with agonist activity at three receptors: the GIP receptor, the GLP-1 receptor and the glucagon receptor. Molecular formula C221H342N46O68, CAS 2381089-83-2.
This material is synthetic retatrutide supplied in solution in a sealed 3 ml multi-dose research pen; it is also available as a 64 mg pen. Identity and purity of each batch are confirmed by HPLC and documented on the published Certificate of Analysis.
In the research literature
In the research literature retatrutide is studied as a tri-agonist: relative potency at the GIP, GLP-1 and glucagon receptors in cell-based signalling assays, and receptor pharmacology in preclinical metabolic models.
Retatrutide is an investigational compound. It is not an authorised medicinal product in the European Union or elsewhere. This material is not a medicine, and nothing on this page describes or implies any effect in humans or animals.
This page identifies a research material. It contains no instructions for use, and no dosing or administration information is provided. For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application.
